Modelling the chloroquine chemotherapy of falciparum malaria: the value of spacing a split dose

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Parasitology

• Publication date

  1998-05-01

• Fields of study

  Biology, Mathematics, Medicine

• Identifiers
  DOI 10.1017/S0031182098002480PMID 9614323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

  1997cited by this paper
• The World Health Report 1997--conquering suffering, enriching humanity.

  1997cited by this paper
• Evidence that recurrent Plasmodium falciparum infection is caused by recrudescence of resistant parasites.

  1997cited by this paper
• Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine

  1997cited by this paper
• Pharmacokinetics of Quinine, Chloroquine and Amodiaquine

  1996cited by this paper
• Plasmodium falciparum: increased proportion of severe resistance (RII and RIII) to chloroquine and high rate of resistance to sulfadoxine-pyrimethamine in Peninsular Malaysia after two decades.

  1996cited by this paper
• Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

  1996cited by this paper
• Localized permanent epidemics: the genesis of chloroquine resistance in Plasmodium falciparum.

  1995cited by this paper
• Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria.

  1995cited by this paper
• Optimal regimens of parenteral quinine.

  1995cited by this paper
• Sensitivity of Plasmodium falciparum to amodiaquine and chloroquine in central Africa: a comparative study in vivo and in vitro.

  1995cited by this paper
• Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria

  1994cited by this paper
• Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen.

  1994cited by this paper
• Antimalarial 4‐aminoquinolines: mode of action and pharmacokinetics

  1994cited by this paper
• Economic prospects for a new antimalarial drug.

  1994cited by this paper
• Antimalarial pharmacokinetics and treatment regimens.

  1992cited by this paper
• Overview: clinical pharmacology of antimalarials.

  1992cited by this paper
• Malaria and pregnancy in Cameroonian women. Effect of pregnancy on Plasmodium falciparum parasitemia and the response to chloroquine.

  1992cited by this paper
• Periodic and chaotic host-parasite interactions in human malaria.

  1991cited by this paper
• Chloroquine-resistant Plasmodium falciparum malaria at Nchelenge, northeastern Zambia. Follow-up on 515 hospital patients.

  1990cited by this paper
• Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine.

  1989cited by this paper
• [The importance of a quantitative assessment of parasitemia in tropical malaria].

  1989cited by this paper
• Treatment of malaria: some considerations and limitations of the current methods of assessment.

  1989cited by this paper
• In vivo efficacy of chloroquine treatment for Plasmodium falciparum in Malawian children under five years of age.

  1986cited by this paper
• In vivo and in vitro assessment of the sensitivity of Plasmodium falciparum to chloroquine in four districts of Tanga region, Tanzania.

  1985cited by this paper
• Chemotherapy of malaria.

  1951cited by this paper

• The Role of Clinical Pharmacology in Chemotherapy of Multidrug‐Resistant Plasmodium falciparum

  2020cites this paper
• Evaluating artesunate-amodiaquine deployment, efficacy and safety: an in silico pharmacological model

  2019cites this paper
• Improving Methods for Analyzing Antimalarial Drug Efficacy Trials: Molecular Correction Based on Length-Polymorphic Markers msp-1, msp-2, and glurp

  2019cites this paper
• Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors

  2019cites this paper
• A Liver Model for Chemoprotection Against Malaria

  2017cites this paper
• Incorporating Stage Specific Drug Action into Pharmacological 1 Modelling of Antimalarial Drug Treatment 2 3

  2016cites this paper
• Quantifying the pharmacology of antimalarial drug combination therapy

  2016cites this paper
• OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimens

  2016cites this paper
• Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug Treatment

  2016cites this paper
• Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness

  2015cites this paper
• Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges

  2015cites this paper
• Running title : Enhancing and restoring antimalarial effectiveness

  2015cites this paper
• Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling

  2014cites this paper
• Making the Most of Clinical Data: Reviewing the Role of Pharmacokinetic-Pharmacodynamic Models of Anti-malarial Drugs

  2014cites this paper
• Pharmacological considerations in the design of anti-malarial drug combination therapies – is matching half-lives enough?

  2014influential citation
• Modeling Within-Host Effects of Drugs on Plasmodium falciparum Transmission and Prospects for Malaria Elimination

  2014cites this paper
• Improving the Role and Contribution of Pharmacokinetic Analyses in Antimalarial Drug Clinical Trials

  2014cites this paper
• Title : Improving the role and contribution of pharmacokinetic analyses in antimalarial drug 1 clinical trials 2 3 4 Running Title : Pharmacokinetics in antimalarial drug trials

  2014cites this paper
• Improving Pharmacokinetic-Pharmacodynamic Modeling to Investigate Anti-Infective Chemotherapy with Application to the Current Generation of Antimalarial Drugs

  2013cites this paper
• Mechanism-Based Model of Parasite Growth and Dihydroartemisinin Pharmacodynamics in Murine Malaria

  2012cites this paper
• Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development

  2012cites this paper
• Development, Evaluation, and Application of an In Silico Model for Antimalarial Drug Treatment and Failure

  2011cites this paper
• Functional characteristics of the malaria parasite's "chloroquine resistance transporter": Implications for chemotherapy

  2010cites this paper
• Infectious disease modelling research progress

  2009cites this paper
• Problems with continuous-time malaria models in describing gametocytogenesis

  2008cites this paper
• Ronald: A Domain-Specific Language to Study the Interactions Between Malaria Infections and Drug Treatments

  2008cites this paper
• Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage?

  2007cites this paper
• Dynamics of immune response and drug resistance in malaria infection

  2006cites this paper
• Treatment of uncomplicated malaria in Guinea-Bissau

  2006cites this paper
• Mechanisms of Resistance of Malaria Parasites to Antifolates

  2005cites this paper
• Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.

  2005cites this paper
• Should chloroquine be laid to rest?

  2005cites this paper
• Gametocyte investment in Malaria

  2004cites this paper
• Mathematical modelling of malaria chemotherapy: combining artesunate and mefloquine

  2002cites this paper
• The role of population pharmacokinetic-pharmacodynamic modelling in antimalarial chemotherapy

  2001cites this paper
• Pharmacokinetic-pharmacodynamic modelling of the anti-malarial activity of mefloquine

  2001cites this paper
• Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of ‘dormancy’, a partial cytostatic effect of the drug, and its implication for treatment regimens

  2000cites this paper
• Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance

  2000cites this paper